Pricing

Log inSign up

Capricor Therapeutics

88 people · 0 jobs
‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán
Chief Executive Officer
Collapse
Aj Bergmann
Chief Financial Officer
Kristi A. H. Elliott
Chief Science Officer
Mark Awadalla
Chief Development Officer (cdo)
Micheal Binks
Chief Medical Officer
KK
Karen Krasney
Evp, General Counsel
Matt Stange
Director Of Commercial

Board & advisors

Frank Litvack
Chairman
George W. Dunbar, Jr.
Director
DM
David B. Musket
Director
Karimah Es Sabar
Director
EJ
Earl M. Collier Jr.
Director
Paul G. Auwaerter
Director
EM
Eugenio Mercuri
Scientific Advisor
OM
Oscar Henry Mayer
Scientific Advisor
PF
Pat Furlong
Scientific Advisor
ME
Michelle Eagle
Scientific Advisor
MT
Michael Taylor
Scientific Advisor
FM
Francesco Muntoni
Scientific Advisor
CM
Craig McDonald
Scientific Advisor
CV
Chet Villa
Scientific Advisor
TF
Timothy Franson
Scientific Advisor
SH
Suzanne Hendrix
Scientific Advisor
PG
Philip J. Gotwals
Director
MK
Michael Kelliher
Director

Teams

+21

Research and Development

25 people · 0 jobs

Leadership Team

3 people · 0 jobs

PC

Finance and Accounting

3 people · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

162 followers

Regeneron

134 followers

Illumina

79 followers

Agilent Technologies

85 followers

Verily Life Sciences

46 followers

Alexion Pharmaceuticals

45 followers

GRAIL

29 followers

Cytiva

19 followers

PerkinElmer

12 followers

Explore companies